Research Catalog
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.
For in vitro laboratory research use only. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+ to purchase.

GLP-1 (Semaglutide) is a synthetic analog of human glucagon-like peptide-1 (GLP-1) with 94% homology to native GLP-1. With the molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and a molecular weight of 4113.6 g/mol (CAS: 910463-68-2), it incorporates a C18 fatty di-acid side chain attached to lysine at position 26 and modified amino acid substitutions at positions 8 (Aib), 34 (Arg), and a truncated C-terminus.
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEA-AEEA-γ-Glu-eicosanedioic acid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-GlyAbulfaraj et al. (2025) investigated GLP-1's binding affinity and receptor interactions in vitro (PMID: 41170292).
PMID: 41170292Sun et al. (2025) investigated GLP-1's binding affinity and receptor interactions in vitro (PMID: 41030574).
PMID: 41030574Published research demonstrates GLP-1 modulates targeted signaling cascades within cell tissue models (PMID: 41170292).
In cellular environments, GLP-1 exhibits selective binding and corresponding pathway activation (PMID: 41030574).
All compounds are sold strictly for laboratory research use. Not for human or animal consumption. These products are not drugs, supplements, or food. Statements have not been evaluated by the FDA. Must be 21+ to purchase. This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.
Scientific Context